Events2Join

Antiarrhythmics


Antiarrhythmic Drugs: Types, Uses and Side Effects - Cleveland Clinic

Antiarrhythmics are medications that treat abnormal heart rhythms.

Antiarrhythmic Medications - StatPearls - NCBI Bookshelf

Indications · Class Ia: Causes moderate degree blockage of fast sodium channels. Drugs include quinidine, procainamide, and disopyramide.

Antiarrhythmics | The Texas Heart Institute®

Antiarrhythmics are used to treat heart rhythm disorders, called arrhythmias , and to lessen the symptoms associated with them. Some of the common symptoms ...

Antiarrhythmics - Heart and Stroke Foundation of Canada

Antiarrhythmic medications prevent and treat abnormal heartbeats (arrhythmias). Problems with your heart's rhythm are caused by a disruption in the heart's ...

Antiarrhythmic agent - Wikipedia

Antiarrhythmic agents, also known as cardiac dysrhythmia medications, are a class of drugs that are used to suppress abnormally fast rhythms (tachycardias), ...

Drug cabinet: Anti-arrhythmics - British Heart Foundation

Flecainide, sotalol (also a beta blocker) and amiodarone are also commonly prescribed for arrhythmias. They have the ability to terminate an arrhythmia and are ...

Medications for Arrhythmias - Merck Manual Professional Edition

Treatment is directed at causes. If necessary, direct antiarrhythmic therapy, including antiarrhythmic drugs, cardioversion-defibrillation, implantable ...

Antiarrhythmic Drugs. Types, Use & Side Effects - Heart Foundation NZ

Side effects · severe chest pain · severe headache · acute shortness of breath (your breathing is so difficult that you feel unsafe) · swelling of your mouth, ...

Classifications of Antiarrhythmic Agents - Medscape Reference

The classification scheme most commonly in use today is the eponymously titled Vaughan Williams classification.

Classification and choice of antiarrhythmic therapies - Barton - 2020

Antiarrhythmic medications are categorised according to where they act on the cardiac action potential, and choice of treatment should take ...

Antiarrhythmic Agents - LiverTox - NCBI Bookshelf

Amiodarone is a well established cause of drug induced liver injury and can cause both an acute as well as a chronic liver injury with cirrhosis.

Class I antiarrhythmics: Sodium channel blockers - Osmosis

We'll focus on class I antiarrhythmics which are further broken down into 1a, 1b, and 1c. All three groups work on Na+ channels in the cardiac myocytes, so ...

Antiarrhythmic Agent - an overview | ScienceDirect Topics

Antiarrhythmic drugs are primarily used to reduce AF prevalence in highly symptomatic individuals, but are assumed to be incapable of complete AF eradication ...

Antiarrhythmics, Class Ic | DrugBank Online

Antiarrhythmics, Class Ic ; Encainide, A voltage-gated sodium channel blocker used for management of atrial or ventricular fibrillation, atrial flutter, and ...

Antiarrhythmic Drug Therapy for Atrial Fibrillation | Circulation

This review will focus primarily on antiarrhythmic drug use in patients with AF in the absence of significant structural heart disease or congestive heart ...

Popular Antiarrhythmics List, Drug Prices and Medication Information

Compare the cost of prescription and generic Antiarrhythmics medications. See information about popular Antiarrhythmics, including the conditions they treat ...

Antiarrhythmics: Nursing pharmacology: Video, Causes, & Meaning

Summary. Antiarrhythmic drugs are used to prevent and treat abnormal and irregular heart rhythms (arrhythmias). These drugs are classified into four major ...

Antiarrhythmic Drug Therapy: Where Do We Go From Here?

Antiarrhythmic drugs have been and will remain the mainstay of the chronic therapy of patients who have cardiac arrhythmias.

Antiarrhythmic Agent - an overview | ScienceDirect Topics

Antiarrhythmic agents are a group of pharmaceuticals that are used to suppress abnormal rhythms of the heart (cardiac arrhythmias)

Pharmacological Effects of Antiarrhythmic Drugs: Review and Update

This article provides an overview of the key pharmacodynamic and pharmacokinetic characteristics of the major antiarrhythmic drugs in use.